Home›Stock Screener›Wockhardt›Quarterly Results

Wockhardt Quarterly Results

Latest Quarter Net Profit
₹73 Cr
QSept 2026
Quarterly Results

Wockhardt quarterly results. In Sept 2026, Wockhardt (WOCKPHARMA) reported revenue ₹980 Cr and net profit ₹73 Cr — revenue +22.0% YoY. View WOCKPHARMA 52-week high low for the annual high/low range and current price position.

WOCKPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

Wockhardt latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit WOCKPHARMA stock price BSE.

  • Revenue of ₹980 Cr in Sept 2026 (-5.0% vs Mar 2026, +22.0% vs Sept 2025)
  • Net Profit of ₹73 Cr in Sept 2026 (-55.5% vs Mar 2026, -11.0% vs Sept 2025)
  • EBITDA of ₹184 Cr in Sept 2026 (-37.0% vs Mar 2026)
  • Operating Margin of 18.0% in Sept 2026 (-5.0pp vs Mar 2026)
  • Earnings Per Share of ₹4.85 in Sept 2026 (-52.6% vs Mar 2026)

Wockhardt Quarterly Results — Revenue, EBITDA, Net Profit & EPS

WOCKPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 980 1,032 960 803 758 -5.0% 22.0%
Net Profit (₹ Cr) 73 164 107 82 -45 - -
EBITDA (₹ Cr) 184 292 223 199 79 - -
EPS (₹) 4.85 10.23 6.55 4.81 -1.57 - -
Operating Margin (%) 18.0% 23.0% 21.0% 23.0% 9.0% - -

WOCKPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

Wockhardt 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore WOCKPHARMA price trends to track price trends across different timeframes.

Profitability Ratios

Profit Margin 7.4%
EBITDA Margin 18.8%
Operating Margin 18.0%
ROE (Annual) 5.5%

Balance Sheet Highlights

Total Assets ₹8,615 Cr
Total Equity ₹5,281 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,712 Cr

Cash Flow Analysis

Operating Cash Flow ₹390 Cr
Investing Cash Flow ₹-231 Cr
Financing Cash Flow ₹-54 Cr
Net Cash Flow ₹105 Cr

Current Market Data

Current Price ₹2187.00
Exchange NSE
Last Updated Nov 19, 2026

WOCKPHARMA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Wockhardt latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores